Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1991-08-20
1992-10-06
Waddell, Frederick E.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514 80, 5142375, 514330, 514404, 514563, A61K 3155, A61K 31675, A61K 31535, A61K 3144
Patent
active
051531917
ABSTRACT:
The invention concerns cholecystokinin antagonists useful in the treatment major and minor forms of depression. Especially useful are CCK.sub.A antagonists such as devazepide and CCK.sub.B antagonists such as L-365,260 and LY262691.
REFERENCES:
patent: 4791215 (1988-12-01), Rovati et al.
patent: 4820834 (1989-04-01), Evans et al.
The Merck Manual, 14th ed. (1982) pp. 1448-1462.
Ann. Rev. Pharmacol. Toxicol., 1991, 31: 469-501, G. N. Woodruff et al., "Cholecystokinin Antagonists".
J. Med. Chem., 1991, 34, 1505-1508, M. J. Yu et al., "Quinazolinone Cholecystokinin-B Receptor Ligands".
Anderson Elizabeth M.
Henley III Raymond J.
Waddell Frederick E.
Warner-Lambert & Company
LandOfFree
Cholecystokinin antagonists useful for treating depression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cholecystokinin antagonists useful for treating depression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cholecystokinin antagonists useful for treating depression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1189175